BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11301346)

  • 41. Possible immortalization of Hodgkin and Reed-Sternberg cells: telomerase expression, lengthening of telomere, and inhibition of apoptosis by NF-kappaB expression.
    Ohshima K; Sugihara M; Haraoka S; Suzumiya J; Kanda M; Kawasaki C; Shimazaki K; Kikuchi M
    Leuk Lymphoma; 2001 Apr; 41(3-4):367-76. PubMed ID: 11378550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS; Chang I; Kim JY; Choi KH; Lee MS
    Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells.
    Watanabe M; Dewan MZ; Taira M; Shoda M; Honda M; Sata T; Higashihara M; Kadin ME; Watanabe T; Yamamoto N; Umezawa K; Horie R
    Lab Invest; 2007 Apr; 87(4):372-82. PubMed ID: 17310217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells.
    Obara H; Takayanagi A; Hirahashi J; Tanaka K; Wakabayashi G; Matsumoto K; Shimazu M; Shimizu N; Kitajima M
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2198-204. PubMed ID: 11031204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis.
    Kim JY; Lee S; Hwangbo B; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
    Biochem Biophys Res Commun; 2000 Jun; 273(1):140-6. PubMed ID: 10873576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition.
    La Ferla-Brühl K; Westhoff MA; Karl S; Kasperczyk H; Zwacka RM; Debatin KM; Fulda S
    Oncogene; 2007 Jan; 26(4):571-82. PubMed ID: 16909119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
    Bergmann MW; Loser P; Dietz R; von Harsdorf R
    J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation.
    Suk K; Kim YH; Chang I; Kim JY; Choi YH; Lee KY; Lee MS
    FEBS Lett; 2001 Apr; 495(1-2):66-70. PubMed ID: 11322949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
    Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
    J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical localization of prolactin receptor (PRLR) to Hodgkin's and Reed-Sternberg cells of Hodgkin's lymphoma.
    Gharbaran R; Onwumere O; Codrington N; Somenarain L; Redenti S
    Acta Histochem; 2021 Jan; 123(1):151657. PubMed ID: 33259941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis.
    Yang B; El Nahas AM; Fisher M; Wagner B; Huang L; Storie I; Barnett D; Barratt J; Smith AC; Johnson TS
    Nephron Exp Nephrol; 2004; 96(2):e39-51. PubMed ID: 14988591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs.
    Kashkar H; Deggerich A; Seeger JM; Yazdanpanah B; Wiegmann K; Haubert D; Pongratz C; Krönke M
    Blood; 2007 May; 109(9):3982-8. PubMed ID: 17185461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation.
    Cervello M; Giannitrapani L; La Rosa M; Notarbartolo M; Labbozzetta M; Poma P; Montalto G; D'Alessandro N
    Int J Mol Med; 2004 May; 13(5):741-8. PubMed ID: 15067380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The biological basis of Hodgkin's lymphoma.
    Horie R; Watanabe T
    Drug News Perspect; 2003 Dec; 16(10):649-56. PubMed ID: 14747844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
    Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
    J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis.
    Fujihara S; Ward C; Dransfield I; Hay RT; Uings IJ; Hayes B; Farrow SN; Haslett C; Rossi AG
    Eur J Immunol; 2002 Feb; 32(2):457-66. PubMed ID: 11813164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma.
    Schmitz R; Stanelle J; Hansmann ML; Küppers R
    Annu Rev Pathol; 2009; 4():151-74. PubMed ID: 19400691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.